Low recurrence rate after deep calf‐vein thrombosis with 6 weeks of oral anticoagulation
Open Access
- 1 July 1998
- journal article
- research article
- Published by Wiley in Journal of Internal Medicine
- Vol. 244 (1) , 79-82
- https://doi.org/10.1046/j.1365-2796.1998.00318.x
Abstract
. Astermark J, Björgell O, Lindén E, Lethagen S, Nilsson P, Berntorp E (University Hospital, Malmö, Sweden). Low recurrence rate after deep calf‐vein thrombosis with 6 weeks of oral anticoagulation. J Intern Med 1998; 244: 79–82.Objectives: To evaluate the recurrence rate after deep calf‐vein thrombosis treated with 6 weeks of oral anticoagulation.Design and subjects: A 2 year follow‐up of 126 consecutive patients admitted to the Department of Internal Medicine with venographically verified deep calf‐vein thrombosis.Results: One hundred and twenty‐six patients were treated with warfarin for 6 weeks, 18 of them having had a previous episode of venous thrombosis (DVT). Eleven patients (8.7%) suffered a recurrent thromboembolic episode within 2 years, four of which were within the first 3 months. Eight of those without a history of DVT had a recurrence (7.4%). Three of these were activated protein C (APC)‐resistant, one was protein C‐deficient and one had malignant melanoma.Eight patients (6.3%) reported minor haemorrhagic complications, but no major bleeding was seen.Conclusion: Our data support the use of a 6 week regimen of secondary oral prophylaxis after a first episode of deep calf‐vein thrombosis in patients without a permanent risk factor. Whether individuals with inherited thrombophilia require prolonged treatment remains to be evaluated.Keywords
This publication has 16 references indexed in Scilit:
- The Risk of Recurrent Venous Thromboembolism in Patients with an Arg506→Gln Mutation in the Gene for Factor V (Factor V Leiden)New England Journal of Medicine, 1997
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- Factor V Leiden and Risks of Recurrent Idiopathic Venous ThromboembolismCirculation, 1995
- A Comparison of Six Weeks with Six Months of Oral Anticoagulant Therapy after a First Episode of Venous ThromboembolismNew England Journal of Medicine, 1995
- Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic rangeChest, 1992
- Optimum duration of anticoagulation for deep-vein thrombosis and pulmonary embolismThe Lancet, 1992
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- NEED FOR LONG-TERM ANTICOAGULANT TREATMENT IN SYMPTOMATIC CALF-VEIN THROMBOSISThe Lancet, 1985
- One‐Month versus Six‐Month Therapy with Oral Anticoagulants after Symptomatic Deep Vein ThrombosisActa Medica Scandinavica, 1985
- Assessment of Anticoagulant Treatment of Venous ThromboembolismAnnals of Surgery, 1969